Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe

Background: Tacrolimus is the calcineurin inhibitor of choice for preventing acute rejection episodes in kidney transplant patients. However, tacrolimus has a narrow therapeutic range that requires regular monitoring of blood concentrations to minimize toxicity. A new once-daily tacrolimus formulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Budde, Klemens, Rostaing, Lionel, Maggiore, Umberto, Piotti, Giovanni, Surace, Daniela, Geraci, Silvia, Procaccianti, Claudio, Nicolini, Gabriele, Witzke, Oliver, Kamar, Nassim, Albano, Laetitia, Büchler, Matthias, Pascual, Julio, Gutiérrez-Dalmau, Alex, Kuypers, Dirk, Wekerle, Thomas, Głyda, Maciej, Carmellini, Mario, Tisone, Giuseppe, Midtvedt, Karsten, Wennberg, Lars, Grinyó, Josep M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397503/
https://www.ncbi.nlm.nih.gov/pubmed/36017158
http://dx.doi.org/10.3389/ti.2021.10225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397503/
https://www.ncbi.nlm.nih.gov/pubmed/36017158
http://dx.doi.org/10.3389/ti.2021.10225

Ejemplares similares